Needs and Preferences of Patients With Head-neck Cutaneous SCC
NCT06046625 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2025-04-04
Summary
The care of patients with high-risk cutaneous squamous cell carcinomas in the head-neck area is complex and requires a multidisciplinary approach. A key component in this care is the need and experience of patients. However, studies on the experiences and needs of patients with high-risk cutaneous squamous cell carcinomas in the head-neck region are lacking.
Conditions
- Cutaneous Squamous Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Squamous Cell Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Squamous Cell Carcinoma of the Head and Neck
- Skin Cancer
- Patient Satisfaction
- High-Risk Cancer
- Preference, Patient
- Decision Making
- Interview
Interventions
- OTHER
-
Regular care with additional administration of a semi-structured interview
Patients receiving regular care. In addition, a semi-structured interview is conducted. The semi-structured interviews take place once after completion of the care pathway (after all appointments for check-ups associated with the treatment). The interview contains questions about the experience of patients with the care, the needs in this care, the experiences with the information received, the support/guidance, the turnaround time, the treatment received and areas for improvement.
Sponsors & Collaborators
-
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
K Mosterd, MD, PhD · Maastricht University Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-01
- Primary Completion
- 2023-11-01
- Completion
- 2025-06-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Reconstructive Surgery For Head And Neck Cancer Patients
NCT00578032 ·Status: COMPLETED
-
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT06236464 ·Status: RECRUITING
-
Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp
NCT05987579 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the Overall Quality of Life After the Neck Dissection Retro-spinal Sector (IIb), in Squamous Cell Carcinomas Clinical and Radiological N0 VADS
NCT02878655 ·Status: UNKNOWN
-
Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck
NCT01952821 ·Status: COMPLETED
-
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
NCT05929547 ·Status: NOT_YET_RECRUITING
-
The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma
NCT02916368 ·Status: UNKNOWN
-
Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck
NCT00206752 ·Status: COMPLETED ·Phase: NA
-
Nutrition and Life QUality Patients With Head and Neck Cancers
NCT02510859 ·Status: COMPLETED ·Phase: NA
-
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
NCT06380686 ·Status: RECRUITING
-
Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT
NCT04996147 ·Status: TERMINATED
-
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
NCT05123950 ·Status: COMPLETED
-
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02778191 ·Status: COMPLETED
-
A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)
NCT05068609 ·Status: COMPLETED
-
Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00623558 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
NCT06575322 ·Status: RECRUITING
-
Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer
NCT03667482 ·Status: COMPLETED ·Phase: PHASE1
-
2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
NCT06492460 ·Status: RECRUITING ·Phase: PHASE3
-
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
NCT00868491 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT01528163 ·Status: COMPLETED ·Phase: PHASE2
-
Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients
NCT02025062 ·Status: COMPLETED ·Phase: NA
-
Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC
NCT04098458 ·Status: COMPLETED ·Phase: NA
-
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT02035527 ·Status: COMPLETED ·Phase: PHASE1
-
Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.
NCT03837613 ·Status: UNKNOWN
-
Evaluation of the Efficacy and Safety of Local Cryotherapy Treatment of Recurrent Head and Neck Cancer in Irradiated Areas: a Pilot Study
NCT05738187 ·Status: RECRUITING ·Phase: NA